Sigachi Industries Limited – Investor Presentation Summary

Key Operational Highlights

  • Global presence: 500+ customers across 65+ countries
  • 4 state-of-the-art manufacturing facilities in Jhagadia, Dahej, Sultanpur & Raichur
  • Combined production capacity of 18,000 MTPA across strategic locations
  • Product range: 100+ products alongside tailored, customer-centric solutions
  • 2000+ global employee base
  • Quality compliance: Facilities accredited with EXCiPACT, WHO-GMP, GMP, SGMP, HACCP, EDQM CEP, FSSAI, USFDA, ISO 9001:2015

Key drivers of operational performance: Expanding capabilities, advancing product innovation, strengthening global market presence

Financial Highlights

Revenue: ₹1,305 Mn (Q2 FY27)

EBITDA: ₹192 Mn (Q2 FY27)

PAT: ₹89 Mn (Q2 FY27)

EPS: ₹0.27 (Basic, Q2 FY27)

Margins: EBITDA Margin 14.72%, PAT Margin 6.82%

YoY comparison: Revenue up 18.09% from ₹1,105 Mn (Q2 FY26), EBITDA up 156% from ₹75 Mn (Q2 FY26)

QoQ comparison: Revenue up 7.58% from ₹1,213 Mn (Q1 FY27), EBITDA up 16.36% from ₹165 Mn (Q1 FY27)

H1 FY27 Revenue: ₹2,517 Mn (5.45% YoY increase from ₹2,387 Mn)

H1 FY27 EBITDA: ₹356 Mn (12.66% YoY increase from ₹316 Mn)

Drivers of financial performance: Higher revenue growth, improved cost management (total expenses increased only 8.05% YoY vs 18.09% revenue growth)

Balance Sheet Snapshot

Total Assets: ₹8,741 Mn (H1 FY27)

Non-Current Assets: ₹4,617 Mn (H1 FY27)

Current Assets: ₹4,124 Mn (H1 FY27)

Equity: ₹5,468 Mn (H1 FY27)

Current Liabilities: ₹2,888 Mn (H1 FY27)

Non-Current Liabilities: ₹385 Mn (H1 FY27)

Financial Health Insights: Strong equity base, manageable debt levels

Capex & Cash Flow Health

Capital Expenditure: Fast-tracking 12,000 MTPA capacity expansion at Dahej-2 facility

Investment Rationale: Elevate total MCC capacity to 30,000 MTPA to support growth ambitions

Strategic & R&D Initiatives

Investments in Innovation: Two state-of-the-art R&D Application lab facilities in Dahej and Jhagadia; New API R&D Center established in Hyderabad now fully operational

Strategic Rationale: Moving up the value chain by introducing value-added and margin accretive products; Expanding into high-growth markets

ESG Performance Q2 FY27

Environment: Completed limited assurance of Scope 1 and Scope 2 GHG emissions for FY2025–26; Established FY2025–26 as revised environmental baseline; Coal consumption intensity: 28.62 GJ/MT; Total energy intensity: 34.70 GJ/MT

Social: 450 safety training man hours; 93 new hires; 5.65% Gender Diversity

Governance: 91.67% average Board meeting attendance; 50% independent board directors

Management Commentary & Growth Outlook

Strategic Outlook: Focus on expanding capabilities, advancing product innovation, and strengthening global market presence; Priority to convert strategic initiatives into measurable outcomes through operational excellence, enhanced efficiency, and continuous innovation

Historical Performance

5 Years Revenue CAGR: 19.92%

5 Years EBITDA CAGR: 6.74%

5 Years PAT CAGR (Before exceptional items): 3.16%

5 Year Average EBITDA Margin (FY22-26): 18.7%

5 Year Average PAT Margin (FY22-26): 13.2%